Abstract:One in thirteen organ transplant recipients (OTRs) develop post-transplant cutaneous squamous cell carcinoma (cSCC), leading to significant morbidity upon disease progression. Although chronic ultraviolet (UV) exposure primarily underlies keratinocyte carcinogenesis, long-term immunosuppression is a critical etiologic risk factor due to reduced systemic surveillance of dysplasia. Calcineurin inhibitors such as tacrolimus are commonly administered to suppress the immune system by blocking T-cell proliferation and preventing donor organ rejection. Contrarily, studies have evinced the off-target effects of immunosuppressives, namely azathioprine and cyclosporine, but not tacrolimus — the most widely used in all immunosuppression. In addition, the preclinical research literature has overlooked the contribution of stromal fibroblasts in the cSCC tumor microenvironment (TME). Hence, we hypothesize that tacrolimus exerts direct carcinogenic effects on keratinocytes and fibroblasts in the skin. We further postulate that tacrolimus enables a tumor-permissive microenvironment by activating dermal fibroblasts to cause aggressive and invasive keratinocyte carcinoma in OTRs. To examine this cellular crosstalk phenomenon, we used human keratinocytes, primary dermal fibroblasts and cSCC cells in mono- and co-cultures to mimic cutaneous and tumor complexities. Next, we assessed the molecular mechanisms utilized by tacrolimus to potentiate tumorigenesis pertinent to cell survival, proliferation and invasion. Herein, we show that tacrolimus promotes cell survival dose-dependently in cSCC cells. We also found that a fibroblast-cSCC spheroid co-culture significantly enhances cell invasion. In a wound-healing migration assay, tacrolimus increased the migratory capacity of normal keratinocytes and cSCC cells. However, cell proliferation remains nebulous due to cyclical dose-response effects in vitro. We then queried whether cell proliferation is affected in vivo using immunodeficient mice, and similar results were observed. We confirmed via immunoblotting that tacrolimus induced elevated expression of proliferation markers at distinct drug concentrations. Altogether, our findings illuminate keratinocyte-stroma interactions and particularly isolate the contributory role of tacrolimus in non-immune mediated cSCC pathogenesis. This knowledge suggests newer immunosuppressives that do not inhibit calcineurin activity may help relieve cutaneous malignancies in transplant recipients. Citation Format: Edwin Kumah, Yash Chhabra, Vania Wang, Agrani Dixit, Ashani Weeraratna, Kristin Bibee. Iatrogenic immunosuppression emplaces tacrolimus to drive squamous skin cancer progression and influence the microenvironment [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 279.

Effects of Tacrolimus on Migration of Melanocytes and Secretion of Cytokines by Cultured Keratinocytes

Effects of tacrolimus on cell proliferation of and secretion of stem cell factors by cultured human keratinocytes

Effect and mechanism of tacrolimus on melanogenesis on A375 human melanoma cells

Effects of NB-UVB combining tacrolimus on the melanogenesis in human melanocytes

High Concentration of Tacrolimus Inhibits Proliferation and Osteoblastic Differentiation of Human Mesenchymal Stem Cells

Abstract 279: Iatrogenic immunosuppression emplaces tacrolimus to drive squamous skin cancer progression and influence the microenvironment

Topical tacrolimus suppresses the expression of vascular endothelial growth factor and insulin-like growth factor-1 in late anagen.

Different Effects of Tacrolimus on Innate and Adaptive Immune Cells in the Allograft Transplantation

The Influonce Oftacrolimus on the Differentiation and Proliferation of T_H 17 Cells in Mice and Themechanism

Effect of Lmmunosuppressants on Secretion of CXCL11/I-TAC by HaCaT Cells

Tacrolimus enhances the invasion potential of hepatocellular carcinoma cells and promotes lymphatic metastasis in a rat model of hepatocellular carcinoma: involvement of vascular endothelial growth factor-C.

Effect of immunosuppressants tacrolimus and mycophenolate mofetil on the keratinocyte UVB response.

The Effects of Phototherapy and Melanocytes on Keratinocytes

The influonce of tacrolimus on the differentiation and proliferation of T_H 17 cells in mice and the mechanism

Therapeutic Effect of Topical Tacrolimus in Vitiligo Treatment

Tacrolimus inhibits oral carcinogenesis through cell cycle control

Tacrolimus Increases the Expression Level of the Chemokine Receptor CXCR2 to Promote Renal Fibrosis Progression.

Effect of Calcipotriol on Melanin Synthesis by Human Melanoeytes

Effects of bFGF and α-MSH on adhesion and migration of human melanocytes in vitro

Effects of cyclosporin A and tacrolimus on biological behaviors of lung cancer A549 cells in nude mice

Expression of HSP70 and the effect of topical tacrolimus on the expression in skin lesions of atopic dermatitis